Understanding the mechanisms of EGF-induced cellular invasion in pancreatic cancer cells therefore is critical, as such insights could provide a means to define subpopulations of tumors more likely to be responsive to these agents and allow for more focused targeting strategies in future drug design [24]. This evidence concerns the gene EGF and familial pancreatic carcinoma.